trump glp 1 deal Novo Nordisk, Lilly strike with to slash weight-loss drug prices Weight-loss drug makers announce pricing

dairy and meat products

Novo Nordisk, the company behind Ozempic and Wegovy, says that they are years away from catching up to the demand of their drugs, and that they have stopped producing starter doses of Wegovy altogether, as they are struggling to keep up with the current number of patients on the drug

What is widely sold online as BPC-157 powder, capsules, or nasal spray is typically labeled for research use only, not for human consumption. That label is not a technicality

In this way, peptides are different from synthetic hormones whose action in the body is unnatural and can cause highs and lows in hormone levels

Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019